Accredited Buildings

JCV & Associates Project Management and Development Inc.

Offices

Avire Tower Unit 602, 6F, Manila, Philippines

Label: IMMUNE™ Powerful - Tenant Office Space

Year: 2023

First Oceanic Property Management Inc.

Offices

5th Floor, Tower B, One Campus Place, Manila, Philippines

Label: IMMUNE™ Resilient - Tenant Office Space

Year: 2022

Menarco Development

Offices

32 St, Taguig, Metro Manila, Philippines

Label: IMMUNE™ Shell & Core Resilient

Year: 2022

St. Catherine's British School

Educational Buildings

Leof. Sofokli Venizelou 77, Likovrisi 141 23, Greece

Label: IMMUNE™ Resilient

Year: 2022

MREIT, Inc.

Offices

1800 Eastwood Avenue, Bagumbayan, Quezon City Manila, Philippines 

Label: IMMUNE™ Shell & Core Powerful

Year: 2022

MREIT, Inc.

Offices

1880 Eastwood Avenue, Bagumbayan, Quezon City Manila, Philippines

Label: IMMUNE™ Shell & Core Powerful

Year: 2022

Navana Holdings Limited

Residential

1 Palace Place, 12 Palace Street, London, SW1E 5BJ, UK

Label: IMMUNE™ Shell & Core Strong

Year: 2021

Genesis Property

Offices

Building H3, West Gate Business District, 24 Preciziei St., Bucharest, Romania

Label: IMMUNE™ Resilient

Year: 2021

Prolojik Limited

Offices

Perspective House, 7 Cliveden O_ce Village, Lancaster Road, High Wycombe, HP12 3YZ, UK

Label: IMMUNE™ Strong

Year: 2021

FUTURE Designs

Logistics & Industrial

The Lighthouse, Fircroft Way, Edenbridge, Kent, TN8 6EJ, UK

Label: IMMUNE™ Strong

Year: 2021

Mace Group

Offices

Mace Group, 155 Moorgate, London, EC2M 6XB

Label: IMMUNE™ Powerful

Year: 2020

Accredited Buildings

Multiple buildings located in Europe, USA, UAE and Asia are currently in the process of obtaining their IMMUNE Building Standard™ certification, recognising their resilience to medical risks and the successful health and wellbeing measures implemented to keep employees safe during a global pandemic and beyond.

We use cookies.

We use cookies in order to personalize and improve your experience on the website.

By continuing to browse the website, you are agreeing to our use of cookies.

Back to top